Premium
The addition of bendamustine to brentuximab vedotin leads to improved rates of complete metabolic remission in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective single‐centre series
Author(s) -
McMillan Annabel,
O'Neill Aideen T.,
Townsend William,
Lambert Jonathan.,
Virchis Andres,
Shah Raakhee,
Menezes Leon,
Humphries Paul,
Von Both Kirsten,
Grandage Victoria,
Carpenter Ben,
Hough Rachael,
Ardeshna Kirit M.,
Daw Stephen
Publication year - 2021
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.17274
Subject(s) - bendamustine , medicine , brentuximab vedotin , salvage therapy , refractory (planetary science) , oncology , surgery , chemotherapy , lymphoma , hodgkin lymphoma , rituximab , physics , astrobiology